{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:47:44Z","timestamp":1791222464145,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Life and Health Guidance Program Project of Dalian"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02604-5","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:46:01Z","timestamp":1746150361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u02511,3-mannosyltransferase promotes the malignant progression of bladder cancer through activating TNF signaling pathway"],"prefix":"10.1186","volume":"30","author":[{"given":"Mulin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"1","key":"2604_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"key":"2604_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, et al. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"issue":"1","key":"2604_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"key":"2604_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00963-y","author":"M Leyderman","year":"2024","unstructured":"Leyderman M, Chandrasekar T, Grivas P, et al. Metastasis development in non-muscle-invasive bladder cancer. Nat Rev Urol. 2024. https:\/\/doi.org\/10.1038\/s41585-024-00963-y.","journal-title":"Nat Rev Urol"},{"key":"2604_CR5","doi-asserted-by":"publisher","first-page":"1332213","DOI":"10.3389\/fimmu.2023.1332213","volume":"14","author":"S Huang","year":"2024","unstructured":"Huang S, Huang Y, Li C, et al. Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis. Front Immunol. 2024;14:1332213.","journal-title":"Front Immunol"},{"key":"2604_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1741-7015-11-13","volume":"11","author":"G Cheung","year":"2013","unstructured":"Cheung G, Sahai A, Billia M, et al. Recent advances in the diagnosis and treatment of bladder cancer. BMC Med. 2013;11:13.","journal-title":"BMC Med"},{"issue":"5","key":"2604_CR7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1021\/jacsau.4c00043","volume":"4","author":"T Pongracz","year":"2024","unstructured":"Pongracz T, Mayboroda OA, Wuhrer M. The human blood N-glycome: unraveling disease glycosylation patterns. JACS Au. 2024;4(5):1696\u2013708.","journal-title":"JACS Au"},{"key":"2604_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.09.006","author":"V Varadharaj","year":"2024","unstructured":"Varadharaj V, Petersen W, Batra SK, et al. Sugar symphony: glycosylation in cancer metabolism and stemness. Trends Cell Biol. 2024. https:\/\/doi.org\/10.1016\/j.tcb.2024.09.006.","journal-title":"Trends Cell Biol"},{"key":"2604_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2024.101890","volume":"73","author":"A Cindri\u0107","year":"2024","unstructured":"Cindri\u0107 A, Pribi\u0107 T, Lauc G. High-throughput N-glycan analysis in aging and inflammaging: state of the art and future directions. Semin Immunol. 2024;73:101890.","journal-title":"Semin Immunol"},{"issue":"1","key":"2604_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajog.2019.08.004","volume":"222","author":"PC Brady","year":"2020","unstructured":"Brady PC, Farland LV, Racowsky C, et al. Hyperglycosylated human chorionic gonadotropin as a predictor of ongoing pregnancy. Am J Obstet Gynecol. 2020;222(1):68.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2604_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/glycob\/cwad046","volume":"33","author":"R Gupta","year":"2023","unstructured":"Gupta R, Ponangi R, Indresh KG. Role of glycosylation in breast cancer progression and metastasis: implications for miRNA. EMT Multidrug Resist Glycobiol. 2023;33(7):545\u201355.","journal-title":"EMT Multidrug Resist Glycobiol"},{"issue":"3","key":"2604_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2023.10.014","volume":"14","author":"Y Lin","year":"2024","unstructured":"Lin Y, Lubman DM. The role of N-glycosylation in cancer. Acta Pharm Sin B. 2024;14(3):1098\u2013110.","journal-title":"Acta Pharm Sin B"},{"issue":"33","key":"2604_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401818","volume":"11","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Niu X, Zhang Z, et al. Glycan profiling in small extracellular vesicles with a SERS microfluidic biosensor identifies early malignant development in lung cancer. Adv Sci (Weinh). 2024;11(33):e2401818.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2604_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-024-01877-2","volume":"9","author":"M Peipp","year":"2024","unstructured":"Peipp M, Dudziak D, Kellner C. Prosaposin hyperglycosylation: a novel tumor immune escape mechanism and implications for cancer immunotherapy. Signal Transduct Target Ther. 2024;9(1):172.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2604_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12964-023-01060-0","volume":"21","author":"L He","year":"2023","unstructured":"He L, Guo Z, Wang W, et al. FUT2 inhibits the EMT and metastasis of colorectal cancer by increasing LRP1 fucosylation. Cell Commun Signal. 2023;21(1):63.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"2604_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008917","volume":"12","author":"Q Li","year":"2024","unstructured":"Li Q, Guo W, Qian Y, et al. Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion and directs liver cancer to immunotherapy. J Immunother Cancer. 2024;12(6):e008917.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2604_CR17","first-page":"198","volume":"20","author":"MC Masone","year":"2023","unstructured":"Masone MC. The role of GALNT7 as a potential diagnostic marker in prostate cancer. Nat Rev Urol. 2023;20(4):198.","journal-title":"Nat Rev Urol"},{"key":"2604_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108666","volume":"177","author":"Z Wu","year":"2024","unstructured":"Wu Z, Su R, Dai Y, et al. Deep pan-cancer analysis and multi-omics evidence reveal that ALG3 inhibits CD8+ T cell infiltration by suppressing chemokine secretion and is associated with 5-fluorouracil sensitivity. Comput Biol Med. 2024;177:108666.","journal-title":"Comput Biol Med"},{"issue":"3","key":"2604_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188904","volume":"1878","author":"SC Selvakumar","year":"2023","unstructured":"Selvakumar SC, Preethi KA, Sekar D. MicroRNAs as important players in regulating cancer through PTEN\/PI3K\/AKT signalling pathways. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188904.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"2604_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13827","volume":"45","author":"KA Preethi","year":"2021","unstructured":"Preethi KA, Sekar D. Dietary microRNAs: current status and perspective in food science. J Food Biochem. 2021;45(7):e13827.","journal-title":"J Food Biochem"},{"issue":"5","key":"2604_CR21","first-page":"256","volume":"73","author":"MS Varshan","year":"2024","unstructured":"Varshan MS, Selvakumar SC, Preethi KA, et al. MicroRNA-34a-3p and its target tumor necrosis factor-\u03b1 in the regulation of South Indian oral squamous cell carcinoma population. Miner Dent Oral Sci. 2024;73(5):256\u201363.","journal-title":"Miner Dent Oral Sci"},{"issue":"1","key":"2604_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-025-02298-7","volume":"24","author":"SY Lim","year":"2025","unstructured":"Lim SY, Boyd SC, Diefenbach RJ, et al. Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment. Mol Cancer. 2025;24(1):99.","journal-title":"Mol Cancer"},{"key":"2604_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-025-03990-9","author":"H Shen","year":"2025","unstructured":"Shen H, Wang Z, Chen Y, et al. Integrative genome-wide aberrant DNA methylation and transcriptome analysis identifies diagnostic markers for colorectal cancer. Arch Toxicol. 2025. https:\/\/doi.org\/10.1007\/s00204-025-03990-9.","journal-title":"Arch Toxicol"},{"issue":"8","key":"2604_CR24","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1097\/JS9.0000000000001516","volume":"110","author":"J Li","year":"2024","unstructured":"Li J, Kong Z, Qi Y, et al. Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T-cell-fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine-learning bioinformatics retrospective study. Int J Surg. 2024;110(8):4911\u201331.","journal-title":"Int J Surg"},{"issue":"1","key":"2604_CR25","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1038\/s41598-025-91475-1","volume":"15","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang Z, Yang C, et al. Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms. Sci Rep. 2025;15(1):7977.","journal-title":"Sci Rep"},{"issue":"7","key":"2604_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00018-022-04365-4","volume":"79","author":"P Liu","year":"2022","unstructured":"Liu P, Lin C, Liu Z, et al. Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy. Cell Mol Life Sci. 2022;79(7):352.","journal-title":"Cell Mol Life Sci"},{"key":"2604_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112875","volume":"140","author":"B Luo","year":"2024","unstructured":"Luo B, Liu X, Zhang Q, et al. ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC. Int Immunopharmacol. 2024;140:112875.","journal-title":"Int Immunopharmacol"},{"key":"2604_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138895","volume":"290","author":"NKA Aasy","year":"2024","unstructured":"Aasy NKA, Sallam MA, Ragab D, et al. CD44-targeted hyaluronic acid coated imiquimod lipid nanocapsules foster the efficacy against skin cancer: attempt to conquer unfavorable side effects. Int J Biol Macromol. 2024;290:138895.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"2604_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41375-024-02473-7","volume":"39","author":"J Calvo","year":"2025","unstructured":"Calvo J, Naguibneva I, Kypraios A, et al. High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL. Leukemia. 2025;39(2):323\u201336.","journal-title":"Leukemia"},{"key":"2604_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jconrel.2024.09.029","volume":"375","author":"SY Yoo","year":"2024","unstructured":"Yoo SY, Kim HY, Kim DH, et al. Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc- in liver cancer: a non-ferroptotic approach. J Control Release. 2024;375:574\u201388.","journal-title":"J Control Release"},{"issue":"16","key":"2604_CR31","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.7150\/ijbs.73431","volume":"18","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang H, Wu J, et al. GALNT1 enhances malignant phenotype of gastric cancer via modulating CD44 glycosylation to activate the Wnt\/\u03b2-catenin signaling pathway. Int J Biol Sci. 2022;18(16):6068\u201383.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2604_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2023.151360","volume":"102","author":"Q Cheng","year":"2023","unstructured":"Cheng Q, Hu X, Zhang X, et al. N-glycosylation at N57\/100\/110 affects CD44s localization, function and stability in hepatocellular carcinoma. Eur J Cell Biol. 2023;102(4):151360.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"2604_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11060-023-04527-9","volume":"166","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Dai Z, Chen Y, et al. Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway. J Neurooncol. 2024;166(1):113\u201327.","journal-title":"J Neurooncol"},{"issue":"1","key":"2604_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12957-025-03692-7","volume":"23","author":"J Zhen","year":"2025","unstructured":"Zhen J, Sun L, Ji L, et al. EDN1 facilitates cisplatin resistance of non-small cell lung cancer cells by regulating the TNF signaling pathway. World J Surg Oncol. 2025;23(1): 71.","journal-title":"World J Surg Oncol"},{"key":"2604_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117071","volume":"177","author":"W Dinghuan","year":"2024","unstructured":"Dinghuan W, Yi K, Jianzhi T, et al. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K\/AKT\/FOXO3a axis and TNF signaling pathway. Biomed Pharmacother. 2024;177:117071.","journal-title":"Biomed Pharmacother"},{"key":"2604_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112487","volume":"137","author":"J Qin","year":"2024","unstructured":"Qin J, Hu S, Lou J, et al. Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer. Int Immunopharmacol. 2024;137:112487.","journal-title":"Int Immunopharmacol"},{"key":"2604_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114009","volume":"202","author":"JJ Sacco","year":"2024","unstructured":"Sacco JJ, Jackson R, Corrie P, et al. A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma. Eur J Cancer. 2024;202:114009.","journal-title":"Eur J Cancer"},{"issue":"3","key":"2604_CR38","volume":"9","author":"H Mazuelas","year":"2024","unstructured":"Mazuelas H, Magall\u00f3n-Lorenz M, Uriarte-Arrazola I, et al. Unbalancing cAMP and Ras\/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas. JCI Insight. 2024;9(3):e168826.","journal-title":"JCI Insight"},{"issue":"1","key":"2604_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41591-024-03361-4","volume":"31","author":"AM Gross","year":"2025","unstructured":"Gross AM, O\u2019Sullivan Coyne G, Dombi E, et al. Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial. Nat Med. 2025;31(1):105\u201315.","journal-title":"Nat Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02604-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02604-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02604-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:46:02Z","timestamp":1746150362000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02604-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2604"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02604-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was conducted in accordance with the principles of the Declaration of Helsinki, and approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (No. PJ-KS-KY-2022\u2013439). Written informed consent was obtained from all participants prior to their involvement in the study. Animal experiments were performed and approval by the Animal Ethics Committee of Dalian Medical University (No. AEE23158).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}